SEQMRD Trademark

Trademark Overview

On Friday, January 17, 2025, a trademark application was filed for SEQMRD with the United States Patent and Trademark Office. The USPTO has given the SEQMRD trademark a serial number of 99007065. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, July 15, 2025. This trademark is owned by Hematogenix Laboratory Services, LLC. The SEQMRD trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes; Medical testing services, namely, next-generation sequencing testing for detection and diagnosis of blood, bone marrow, and lymph node cancers, namely, leukemias and lymphomas
seqmrd

General Information

Serial Number99007065
Word MarkSEQMRD
Filing DateFriday, January 17, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, July 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2025

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes; Medical testing services, namely, next-generation sequencing testing for detection and diagnosis of blood, bone marrow, and lymph node cancers, namely, leukemias and lymphomas

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 17, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHematogenix Laboratory Services, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTinley Park, IL 60487

Trademark Events

Event DateEvent Description
Friday, January 17, 2025NEW APPLICATION ENTERED
Friday, January 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 27, 2025ASSIGNED TO EXAMINER
Friday, June 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

seqmrd testing medical namely lymph bone marrow node lymphomas leukemias cancers